Organization
Oslo University Hospital, Oslo, Norway
7 abstracts
Abstract
An international randomized phase III trial comparing radical hysterectomy and pelvic node dissection (RH) vs simple hysterectomy and pelvic node dissection (SH) in patients with low-risk early-stage cervical cancer (LRESCC): A Gynecologic Cancer Intergroup study led by the Canadian Cancer Trials Group (CCTG CX.5-SHAPE).Org: University of British Columbia, Vancouver, BC, Canada, Gynecologic Oncology, Centre Hospitalier de l’Université de Montréal (CHUM), Centre de Recherche de l’Université de Montréal (CRCHUM), Université de Montréal, Montreal, QC, Canada, Gustave Roussy Cancer Center, Villejuif, France, Netherlands Cancer Institute, Amsterdam, Netherlands, Innsbruck Medical University; Department of Obstetrics and Gynecology, Innsbruck, Austria,
Abstract
Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): An international randomised trial.Org: Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, -, Netherlands, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, Netherlands, Department of Surgery, Linköping University Hospital and Department of Biomedical and Clinical Sciences, Linköping University, Linkøping, Sweden, Universitá di Pisa, Pisa, Italy,
Abstract
Sex differences in localized gastrointestinal stromal tumor.Org: Oslo University Hospital, Oslo, Norway,
Abstract
ALTERED IMMUNE RECOGNITION OF SPECIFIC GUT BACTERIA BY IMMUNOGLOBULINS IN EARLY SYSTEMIC SCLEROSISOrg: Oslo University Hospital, Oslo, Norway, Lund University Hospital, Lund, Sweden, NTNU, Trondheim, Norway,
Abstract
ANTI-RHEUMATIC THERAPY REDUCES SYNDECAN-1 SHEDDING IN RHEUMATOID ARTHRITIS (RA) Org: Lillehammer Hospital for rheumatic diseases, Lillehammer, Norway, University of Oslo, Oslo, Innlandet Hospital Trust, Lillehammer, Oslo University Hospital, Oslo, Norway, Statens Serum Institut, Coepenhagen, Denmark,
Abstract
AUGMENTED CONCENTRATIONS OF CX3CL1 ARE ASSOCIATED WITH PROGRESSIV INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS Org: Oslo University Hospital, Oslo, Norway, University of California Los Angeles, Los Angeles, United States,
Abstract
ANTI-CENTROMERE ANTIBODY ISOTYPE LEVELS AS BIOMARKER FOR DISEASE PROGRESSION IN SUBJECTS AT RISK TO DEVELOP SYSTEMIC SCLEROSISOrg: Leiden University Medical Center (LUMC), Leiden, Netherlands, Zurich University Hospital, Zurich, Switzerland, Oslo University Hospital, Oslo, Norway, Ghent University Hospital, Ghent, Belgium, Bordeaux University Hospital, Bordeaux, France,